The change, stated precisely

Featured image for The change, stated precisely

From summer 2026, pharmacists who trained under the 2021 education standards join the register as independent prescribers from day one, which is a genuine step change for the profession. The Common Registration Assessment they must pass, however, is stable, and, importantly, it does not test prescribing at all. The exam's format and content are consistent across training routes precisely because prescribing was kept out of it. Here is what the summer 2026 cohort actually faces, and why the change matters even though the paper has not.

Key takeaways

  • Pharmacists trained under the 2021 standards are annotated as prescribers at registration from 2026.
  • The prescriber annotation comes from the training route and foundation year, not from the CRA.
  • The CRA deliberately excludes independent-prescribing content to stay fair across all routes.
  • The exam is two parts, both passed in one sitting with no compensation, and calculations sink many candidates.
  • The stakes of practice rise with day-one prescribing, even though the exam's content is unchanged.

The 2021 initial education and training standards embedded independent prescribing into the pharmacist qualification, so pharmacists whose degree was accredited to those standards, and who complete their foundation training year and pass the registration assessment, receive an annotation on the GPhC register allowing them to practise as independent prescribers from the point of registration. The GPhC has published advice for these newly qualified prescribers on scope, competence, and employer support. This is the real change: not the exam, but what a newly registered pharmacist is authorised to do.

Why the CRA does not test prescribing

Here is the part that trips people up. The act of prescribing, the relevant learning outcome, is not assessed in the CRA. That is deliberate, because not everyone sitting the assessment in 2026 trained under the 2021 standards: there are also trainees from earlier, interim standards and from overseas pharmacist assessment programmes whose training did not include prescribing, and those pharmacists complete an accredited prescribing course after registration instead. To keep the assessment fair and common across all these routes, prescribing content was excluded, and the prescribing competence of 2021-standards trainees is signed off through their foundation training year rather than the exam. So the paper is stable in part because prescribing was taken out of it.

What the CRA actually tests

The CRA is two papers sat on one day, delivered by computer at a test centre. Part 1 is 40 free-entry numerical calculation questions in 120 minutes, closed-book, with a GPhC-approved or on-screen calculator permitted from 2026. Part 2 is 120 selected-response questions, 90 single-best-answer and 30 extended-matching, over 150 minutes. Content spans clinical therapeutics, including high-risk drug classes and safety alerts, law, governance and regulation, and pharmaceutical calculations, all framed around applied, person-centred decision-making rather than recall. The critical rule is that you must pass both parts in the same sitting, with no compensation and no averaging, and there is a maximum of three lifetime attempts. The Board of Assessors sets the standard and publishes feedback after each sitting.

Why the prescribing era raises the bar in practice

The framework is explicit that the assessment standard is unchanged, so the CRA is no harder than before. But the stakes of the knowledge it tests are higher, because a pharmacist who can prescribe from day one carries more clinical responsibility than one who cannot. Safe dosing, recognising interactions, adjusting for renal impairment, and spotting prescribing errors are no longer only about checking someone else's decision; increasingly they underpin the pharmacist's own. So while the exam is stable, the professional context around it has shifted, and the applied clinical judgement the CRA tests matters more than it used to.

Calculations: the classic failure point

Part 1 is where sittings are quietly lost. Because you must pass both parts in one sitting, failing calculations wastes the whole attempt regardless of how well you did on Part 2, and recent sittings show this is no edge case: a meaningful minority of candidates fail Part 1 alone, with the calculation pass mark set per sitting. The fix is specific: treat calculations as a distinct, timed skill, not an afterthought to clinical revision. Drill the high-risk types, dose and weight-based dosing, unit conversions, infusion rates, displacement values, concentration expressions, and renal dose adjustment, under time pressure until they are automatic. The iatroX GPhC bank covers all three question formats, single-best-answer, extended-matching, and free-entry calculations, with an engine that targets your weakest areas, and you can try it with free sample questions at iatroX.

The pipeline ahead

One further development is worth watching: the GPhC has been consulting on a route for internationally qualified pharmacists, which, if implemented, would bring more candidates into future CRA cohorts. Confirm the current position on the GPhC website, as this is developing. For now, the summer 2026 cohort should plan around the assessment as it stands.

Sitting logistics for 2026

There are two sittings in 2026, in June and November, delivered at test centres, with results released several weeks after the assessment day. Eligibility requires completion of the foundation training year by the application deadline and sign-off by your designated supervisor, and registration is made through the GPhC portal before the cut-off. Confirm the exact 2026 dates and deadlines on the official GPhC page before booking, since missing a deadline means waiting for the next sitting.

Frequently asked questions

Does passing the CRA make me an independent prescriber? Not by itself. The prescriber annotation comes from completing a 2021-standards accredited degree and foundation training year, where prescribing is signed off. The CRA does not test prescribing and is not the route to the annotation.

Why does the CRA not test prescribing? To keep it fair and common across all routes, since some 2026 candidates trained under earlier standards or overseas programmes without prescribing. Prescribing content was excluded so every candidate sits the same assessment.

What is the format of the CRA? Two papers on one day: Part 1 is 40 free-entry calculations in 120 minutes, and Part 2 is 120 selected-response questions in 150 minutes. You must pass both in the same sitting, with no compensation, and have a maximum of three attempts.

Why do candidates fail the CRA? Frequently on Part 1 calculations, which must be passed in the same sitting as Part 2. Treating calculations as a separate timed skill, rather than an afterthought, is the single highest-yield preparation change.

Has the CRA got harder because of prescribing? No. The framework keeps the standard and content consistent, and prescribing is excluded. What changed is the professional responsibility of newly registered pharmacists, not the difficulty of the exam.

Share this insight